Usutu virus growth in human cell lines: Induction of and sensitivity to type I and III interferons

Journal of General Virology

Volumn 94, Issue PART4, 2013, Pages 789-795

  Scagnolari, Carolina ^a   Caputo, Beniamino ^a   Trombetti, Simona ^a   Cacciotti, Giulia ^a   Soldà, Annalisa ^a   Spano, Lucia ^a   Villari, Paolo ^a   della Torre, Alessandra ^a   Nowotny, Norbert ^b,c   Antonelli, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c Sultan Qaboos University College of Medicine and Health Sciences   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; TYPE I INTERFERON; TYPE III INTERFERON; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FLAVIVIRUS INFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION SENSITIVITY; INTERFERON PRODUCTION; JAPANESE ENCEPHALITIS VIRUS; MICROBIAL SENSITIVITY TEST; NONHUMAN; PRIORITY JOURNAL; STIMULATION; USUTU FLAVIVIRUS; VIROGENESIS; VIRUS INDUCTION; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 84875682341     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.046433-0     Document Type: Article

References (32)

1. Anderson, J. F. & Rahal, J. J. (2002). Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 8, 107-108.
2. Ank, N., West, H., Bartholdy, C., Eriksson, K., Thomsen, A. R. & Paludan, S. R. (2006). Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 80, 4501-4509.
3. Bakonyi, T., Lussy, H., Weissenbock, H., Hornyák, A. & Nowotny, N. (2005). In vitro host-cell susceptibility to Usutu virus. Emerg Infect Dis 11, 298-301.
4. Brass, A. L., Huang, I. C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L. & other authors (2009). The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254.
5. Cavrini, F., Gaibani, P., Longo, G., Pierro, A. M., Rossini, G., Bonilauri, P., Gerundi, G. E., Di Benedetto, F., Pasetto, A. & other authors (2009). Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August-September 2009. Euro Surveill 14, 50.
6. Cavrini, F., Pepa, M. E. D., Gaibani, P., Pierro, A. M., Rossini, G., Landini, M. P. & Sambri, V. (2011). A rapid and specific real-time RT-PCR assay to identify Usutu virus in human plasma, serum, and cerebrospinal fluid. J Clin Virol 50, 221-223.
7. Chvala, S., Bakonyi, T., Bukovsky, C., Meister, T., Brugger, K., Rubel, F., Nowotny, N. & Weissenbock, H. (2007). Monitoring of Usutu virus activity and spread by using dead bird surveillance in Austria, 2003-2005. Vet Microbiol 122, 237-245.
8. Colpitts, T. M., Barthel, S., Wang, P. & Fikrig, E. (2011). Dengue virus capsid protein binds core histones and inhibits nucleosome formation in human liver cells. PLoS ONE 6, e24365.
9. Daffis, S., Suthar, M. S., Gale, M., Jr & Diamond, M. S. (2009). Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. J Innate Immun 1, 435-445.
10. Diamond, M. S., Roberts, T. G., Edgil, D., Lu, B., Ernst, J. & Harris, E. (2000). Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74, 4957-4966.
11. Faul, E. J., Lyles, D. S. & Schnell, M. J. (2009). Interferon response and viral evasion by members of the family Rhabdoviridae. Viruses 1, 832-851.
12. Gaibani, P., Pierro, A., Alicino, R., Rossini, G., Cavrini, F., Landini, M. P. & Sambri, V. (2012). Detection of Usutu-virus-specific IgG in blood donors from northern Italy. Vector Borne Zoonotic Dis 12, 431-433.
13. Hoenen, A., Liu, W., Kochs, G., Khromykh, A. A. & Mackenzie, J. M. (2007). West Nile virus-induced cytoplasmic membrane structures provide partial protection against the interferon-induced antiviral MxA protein. J Gen Virol 88, 3013-3017.
14. Kelly, C., Klenerman, P. & Barnes, E. (2011). Interferon lambdas: the next cytokine storm. Gut 60, 1284-1293.
15. Marcello, T., Grakoui, A., Barba-Spaeth, G., Machlin, E. S., Kotenko, S. V., MacDonald, M. R. & Rice, C. M. (2006). Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131, 1887-1898.
16. Meager, A., Visvalingam, K., Dilger, P., Bryan, D. & Wadhwa, M. (2005). Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 31, 109-118.
17. Morrison, J., Aguirre, S. & Fernandez-Sesma, A. (2012). Innate immunity evasion by Dengue virus. Viruses 4, 397-413.
18. Pastorino, B., Boucomont-Chapeaublanc, E., Peyrefitte, C. N., Belghazi, M., Fusaï, T., Rogier, C., Tolou, H. J. & Almeras, L. (2009). Identification of cellular proteome modifications in response to West Nile virus infection. Mol Cell Proteomics 8, 1623-1637.
19. Pecorari, M., Longo, G., Gennari, W., Grottola, A., Sabbatini, A., Tagliazucchi, S., Savini, G., Monaco, F., Simone, M. & other authors (2009). First human case of Usutu virus neuroinvasive infection, Italy, August-September 2009. Euro Surveill 14, 50.
20. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am J Hyg 27, 493-497.
21. Samuel, M. A. & Diamond, M. S. (2005). Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79, 13350-13361.
22. Sangiambut, S., Keelapang, P., Aaskov, J., Puttikhunt, C., Kasinrerk, W., Malasit, P. & Sittisombut, N. (2008). Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection. J Gen Virol 89, 1254-1264.
23. Scagnolari, C., Vicenzi, E., Bellomi, F., Stillitano, M. G., Pinna, D., Poli, G., Clementi, M., Dianzani, F. & Antonelli, G. (2004). Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antivir Ther 9, 1003-1011.
24. Scagnolari, C., Trombetti, S., Cicetti, S., Antonelli, S., Selvaggi, C., Perrone, L., Visca, M., Romano, S. & Antonelli, G. (2008). Severe acute respiratory syndrome coronavirus elicits a weak interferon response compared to traditional interferon-inducing viruses. Intervirology 51, 217-223.
25. Scagnolari, C., Trombetti, S., Selvaggi, C., Carbone, T., Monteleone, K., Spano, L., Di Marco, P., Pierangeli, A., Maggi, F. & other authors (2011). In vitro sensitivity of human metapneumovirus to type I interferons. Viral Immunol 24, 159-164.
26. Su, H. L., Liao, C. L. & Lin, Y. L. (2002). Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response. J Virol 76, 4162-4171.
27. Tu, Y. C., Yu, C. Y., Liang, J. J., Lin, E., Liao, C. L. & Lin, Y. L. (2012). Blocking double-stranded RNA-activated protein kinase PKR by Japanese encephalitis virus nonstructural protein 2A. J Virol 86, 10347-10358.
28. Vazquez, A., Jimenez-Clavero, M., Franco, L., Donoso-Mantke, O., Sambri, V., Niedrig, M., Zeller, H. & Tenorio, A. (2011). Usutu virus: potential risk of human disease in Europe. Euro Surveill 16, 31.
29. Weissenbock, H., Kolodziejek, J., Url, A., Lussy, H., Rebel-Bauder, B. & Nowotny, N. (2002). Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, central Europe. Emerg Infect Dis 8, 652-656.
30. Weissenbock, H., Kolodziejek, J., Fragner, K., Kuhn, R., Pfeffer, M. & Nowotny, N. (2003). Usutu virus activity in Austria, 2001-2002. Microbes Infect 5, 1132-1136.
31. Westaway, E. G., Khromykh, A. A., Kenney, M. T., Mackenzie, J. M. & Jones, M. K. (1997). Proteins C and NS4B of the flavivirus Kunjin translocate independently into the nucleus. Virology 234, 31-41.
32. Yu, C. Y., Hsu, Y. W., Liao, C. L. & Lin, Y. L. (2006). Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J Virol 80, 11868-11880.